MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$485,385
Net Income
$40,418
Net Profit Margin
8.33%
Unit: Dollar
Revenue Breakdown
Medical Procedures
Sales Of Biologics
Shipping And Delivery
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
Total revenue
485,385
176,275
175,127*
Total revenue-Supplements
-
-
323.75*
Supplements
0
0
-
Total revenue-Procedures
-
-
54,488.75*
Procedures
82,588
70,962
-
Total revenue-Biologics
-
-
72,397*
Biologics
120,217
37,736
-
Total cost of revenue
202,805
108,698
127,209.5*
Gross profit
282,580
67,577
47,917.5*
General and administrative
23,175
33,778
12,847.25*
Advertising and promotion
22,436
37,007
19,551.75*
Clinical trial fees
7,175
4,850
1,725*
Corporate filings
-
4,005
4,627.5*
Corporate filing fees
7,723
-
-
Equipment leases
6,696
6,696
7,946*
Legal and professional fees
81,922
78,809
34,506.5*
Public relations
2,480
-
-
Repairs and maintenance
1,152
-
672*
Public relations
-
2,440
4,198.75*
Repairs and maintenance
-
1,010
1,321*
Rent
19,748
16,183
16,159*
Research and development
0
-
7,286*
Salaries and wages
55,129
32,602
15,441.75*
Shared-based compensation
-
-
10,562.5*
Utilities
1,672
866
1,585.75*
Depreciation and amortization
1,443
1,251
1,109.75*
Total operating expenses
230,751
219,497
139,540.5*
Income (loss) from operations
51,829
-151,920
-91,623*
Interest income
375
375
156.25*
Sublease income
-
-
500*
Interest expense related party
11,786
10,980
7,899.25*
Total other income (expense)
-11,411
-10,605
-7,243*
Net income (loss) before provision for income taxes
40,418
-162,525
-98,866*
Provision for income taxes
0
0
0*
Net income (loss)
40,418
-162,525
-98,866
Basic EPS
0
0
-0.001
Diluted EPS
0
0
-0.001
Basic Average Shares
94,404,696
94,404,696
93,596,730
Diluted Average Shares
161,404,696
94,404,696
93,596,730
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ADIA Income Statement Sankey Diagram
Sankey diagram visualizing ADIA income statement for the period
Medical Procedures
$329,820
Sales Of Biologics
$151,750
Shipping And Delivery
$3,815
Total revenue
$485,385
Gross profit
$282,580
Total cost of revenue
$202,805
Income (loss) from
operations
$51,829
Total operating
expenses
$230,751
Biologics
$120,217
Procedures
$82,588
Net income (loss)
before provision for...
$40,418
Total other income
(expense)
-$11,411
Interest income
$375
Legal and
professional fees
$81,922
Salaries and wages
$55,129
General and
administrative
$23,175
Advertising and promotion
$22,436
Rent
$19,748
Corporate filing fees
$7,723
Clinical trial fees
$7,175
Equipment leases
$6,696
Public relations
$2,480
Utilities
$1,672
Depreciation and
amortization
$1,443
Repairs and maintenance
$1,152
Net income (loss)
$40,418
Interest expense related
party
$11,786
Buy us a coffee
Adia Nutrition, Inc. (ADIA)
Adia Nutrition, Inc. (ADIA)